Tildrakizumab in real-life shows good efficacy in moderate-to-severe psoriasis regardless of previous use of biologic drugs and joint involvement.
Luca MastorinoCaterina CaritiSara SuscaNadia SciamarrelliSilvia BorrielloMichela OrtoncelliElena StroppianaAnna VerronePaolo DapavoPietro QuaglinoSimone RiberoPublished in: Dermatologic therapy (2022)